On August 11, Rocket Lab USA, Inc. declined 5.15% in regular trading, trading at $76.18/share, with turnover of $639 million.

The decline follows the company's Q2 earnings release, which showed mixed results. Revenue rose 62% year-over-year to $234.1 million, slightly beating the $231.6 million consensus, while EPS of -$0.08 missed analyst expectations of -$0.06 to -$0.07. More critically, the company guided Q3 GAAP gross margin at just 29%-31%, far below the Street's 37.6% average estimate, citing shifts in product sales mix.

Additionally, Rocket Lab signaled that its Neutron rocket first flight window is narrowing, with the launch potentially delayed to next year. While the rocket is still expected to reach the launch pad in Q4, the company no longer maintains its year-end first flight target. Despite record backlog of $2.36 billion, Q3 revenue guidance of $250-$265 million above consensus, and a recent $397 million US Space Force contract, the triple headwinds of earnings miss, margin guidance cut, and Neutron delay risk dominated selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)